Ohio § 3922.20 Admissibility of written decision or medicare reimbursement standards

Ohio Statutes

§ 3922.20 — Admissibility of written decision or medicare reimbursement standards

Ohio § 3922.20

Title 39Insurance

Ch. 3922External Review

This text of Ohio § 3922.20 (Admissibility of written decision or medicare reimbursement standards) is published on Counsel Stack Legal Research, covering Ohio primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Ohio Rev. Code Ann. § 3922.20 (2026).

Text

Consistent with the Rules of Evidence, a  written decision or opinion prepared by an independent review  organization under this chapter shall be admissible in any civil  action related to the coverage decision that was the subject of  the decision or opinion. The independent review organization's  decision or opinion shall be presumed to be a scientifically valid  and accurate description of the state of medical knowledge at the  time it was written.

Consistent with the Rules of Evidence, any party to a civil  action related to a plan's decision involving an investigational  or experimental drug, device, or treatment may introduce into  evidence any applicable medicare reimbursement standards  established under Title XVIII of the "Social Security Act," 49  Stat. 620 (1935), 42 U.S.C.A. 3

Free access — add to your briefcase to read the full text and ask questions with AI

Consistent with the Rules of Evidence, a written decision or opinion prepared by an independent review organization under this chapter shall be admissible in any civil action related to the coverage decision that was the subject of the decision or opinion. The independent review organization's decision or opinion shall be presumed to be a scientifically valid and accurate description of the state of medical knowledge at the time it was written.

Consistent with the Rules of Evidence, any party to a civil action related to a plan's decision involving an investigational or experimental drug, device, or treatment may introduce into evidence any applicable medicare reimbursement standards established under Title XVIII of the "Social Security Act," 49 Stat. 620 (1935), 42 U.S.C.A. 301, as amended.